MSH6 and gastric cancer: Comparing the results of the present study and our previous study [9] in colorectal cancer, we observed that MSH6 and EXO1 genetic mutations were higher in EMAST+/MSI-H tumors than other subtypes, in both GC and colorectal cancer.